Methylphenidate in Treatment of ADHD and Comorbid Chronic Tic Disorder
The safety and efficacy of immediate-release methylphenidate (MPH-IR) for the treatment of attention deficit hyperactivity disorder (ADHD) in children (ages 6-12 years) with Tourette's syndrome (96%) or chronic motor tic disorder (4%) were evaluated at State University of New York, Stony Brook.
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Pediatric Neurology Briefs Publishers
2007-07-01
|
| Serie: | Pediatric Neurology Briefs |
| Soggetti: | |
| Accesso online: | https://www.pediatricneurologybriefs.com/articles/1010 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|